Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Developing site-specific and novel-format Antibody-Drug Conjugates (ADCs)62.04M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States62.04M100.00%